Indrani Lall Franchini Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

Indrani Lall Franchini is EVP, Chief Compliance Officer of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 116,075 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Indrani Lall Franchini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	116,075 Reduced 100.0%	0 Common Stock, par valu...
Jul 14 2021	BUY Grant, award, or other acquisition	-	52,625 Added 31.19%	116,075 Common Stock, par valu...
Jun 08 2021	SELL Payment of exercise price or tax liability	$164,256 $177.0 p/Share	928 Reduced 1.44%	63,450 Common Stock, par valu...
Feb 28 2021	BUY Grant, award, or other acquisition	-	18,033 Added 21.88%	64,378 Common Stock, par valu...
Dec 16 2020	SELL Payment of exercise price or tax liability	$3,133,611 $157.96 p/Share	19,838 Reduced 29.97%	46,345 Common Stock, par valu...
Dec 16 2020	BUY Grant, award, or other acquisition	-	37,965 Added 36.45%	66,183 Common Stock, par valu...

Also insider at

ALNY

ALNYLAM PHARMACEUTICALS, INC. Healthcare

EVP, CLO & Secretary

ILF